Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Prometic Biotherapeutics Ltd
Cambridge (Sawston), Cambridgeshire, United Kingdom
- Ownership
- Private
- Employees
- ~160
- Development stage
- Other
01
Overview
The company developed plasma-based therapeutic products and small molecule therapeutics. It was acquired by Kedrion on June 28, 2021.
- Therapeutic areas
- ImmunologyRare DiseasesCardiovascularMetabolic Disorders
- Modalities
- Small moleculesPlasma-derived therapeutics
- Industry
- Biotech
02
Partnerships
American Red Cross (2000)
Beyond the preview
Go deeper on Prometic Biotherapeutics Ltd.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Prometic Biotherapeutics Ltd.